Tony Butler
Stock Analyst at Rodman & Renshaw
(0.75)
# 4,064
Out of 5,124 analysts
88
Total ratings
32.61%
Success rate
-13.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $18.09 | +38.20% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $0.76 | +1,353.68% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.24 | +1,351.61% | 4 | Sep 26, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.99 | +1,508.36% | 5 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $0.98 | +917.71% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $52.44 | +43.02% | 8 | Aug 8, 2023 | |
| GTBP GT Biopharma | Reiterates: Hold | $60 | $0.79 | +7,541.37% | 5 | Aug 7, 2023 | |
| CGEN Compugen | Reiterates: Buy | $13 | $1.53 | +749.67% | 6 | Aug 7, 2023 | |
| BCYC Bicycle Therapeutics | Reiterates: Buy | $50 | $7.05 | +609.22% | 5 | Aug 3, 2023 | |
| ALLO Allogene Therapeutics | Reiterates: Buy | $15 | $1.37 | +994.89% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.57 | +4,303.73% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.15 | +1,204.35% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.26 | +90.11% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $6.59 | +157.97% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $3.14 | +5,186.62% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $9.72 | +517.28% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.34 | +10,156.41% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.26 | +2,247.42% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $0.97 | +36,990.46% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $5.84 | -65.75% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.51 | +893.38% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.49 | +571.14% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $5.37 | +179.33% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $8.99 | +1,123.58% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $960 | $14.19 | +6,665.33% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $18.09
Upside: +38.20%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $0.76
Upside: +1,353.68%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.24
Upside: +1,351.61%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.99
Upside: +1,508.36%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $0.98
Upside: +917.71%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $52.44
Upside: +43.02%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.79
Upside: +7,541.37%
Compugen
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.53
Upside: +749.67%
Bicycle Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.05
Upside: +609.22%
Allogene Therapeutics
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.37
Upside: +994.89%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.57
Upside: +4,303.73%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.15
Upside: +1,204.35%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $5.26
Upside: +90.11%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $6.59
Upside: +157.97%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $3.14
Upside: +5,186.62%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $9.72
Upside: +517.28%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.34
Upside: +10,156.41%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.26
Upside: +2,247.42%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $0.97
Upside: +36,990.46%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $5.84
Upside: -65.75%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $1.51
Upside: +893.38%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.49
Upside: +571.14%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $5.37
Upside: +179.33%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $8.99
Upside: +1,123.58%
Mar 2, 2020
Initiates: Buy
Price Target: $960
Current: $14.19
Upside: +6,665.33%